Real-time enrollment status for this macular degeneration clinical trial
Current Status
Completed
Checked: June 1, 2026 at 8:25 PM UTC
| NCT Number | NCT06704009 |
| Recruiting Status | Completed |
| Condition | Macular Degeneration |
| Phase | Clinical Trial |
| Target Enrollment | 30 participants |
| Active Locations | 4 sites in the US |
| Sponsor | NexThera Co., Ltd. |
| Last Updated on CT.gov | May 19, 2026 (1 week ago) |
As of June 1, 2026: Clinical trial NCT06704009 is currently completed participants. This clinical trial study for macular degeneration is not currently accepting new participants at 4 locations across the United States. The study is sponsored by NexThera Co., Ltd.. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06704009 is currently completed. The study may resume recruiting in the future.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06704009 was last updated 1 week ago (May 19, 2026). HelloStudys verifies this status automatically.